EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cyclin‐Dependent Kinase 11: Cellular Functions and Potential Therapeutic Applications

Janhabee Shrestha, Jason Blanchard, Solomon Tadesse iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500305 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemMedChem, 2025. Verfasst von Janhabee Shrestha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical and Pharmaceutical Sciences, L. S. Skaggs College of Pharmacy, Kasiska Division of Health Sciences, Idaho State University, Pocatello, ID,…. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinases, Protein Kinase Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 142 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclin‐dependent kinase 11 (CDK11) is a multifunctional serine/threonine protein kinase that plays a pivotal role in transcription and pre‐mRNA splicing. It phosphorylates serine 2 of RNA polymerase II C‐terminal domain, thereby promoting transcriptional elongation and 3′‐end processing of replication‐dependent histone genes. CDK11 also contributes to proper chromosome segregation during mitosis. As a key regulator of global pre‐mRNA splicing, CDK11 activates the spliceosome, by phosphorylating Splicing Factor 3B Subunit 1, a core component of the U2 small nuclear ribonucleoprotein complex. Given the tight coupling between splicing, transcription, and cell proliferation, inhibition of CDK11 is hypothesized to impair both general transcription and cell cycle progression. CDK11 drives cancer cell proliferation, promotes HIV‐1 mRNA 3′‐end processing to enhance viral replication, and contributes to tau phosphorylation in Alzheimer's disease. Owing to itscentral role in key cellular processes and its dysregulation in various diseases, CDK11 has emerged as a compelling therapeutic target. This review provides a comprehensive overview of the biological functions and regulatory mechanisms of CDK11, discusses its role in cancer, viral, and neurodegenerative diseases, and highlights advances in the discovery and development of CDK11 inhibitors, including OTS964, which has expanded our understanding of the biological functions of CDK11 and its prospects as a cancer‐specific vulnerability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent KinasesProtein Kinase InhibitorsHumansNeoplasmsNeurodegenerative DiseasesAnimalsAntineoplastic AgentsCell Proliferation

Stichwörter der Autor:innen

RNA splicingcancergene transcriptioninhibitorstherapeutic target

Substanzen

Cyclin-Dependent KinasesProtein Kinase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Biomedical and Pharmaceutical Sciences, L. S. Skaggs College of Pharmacy, Kasiska Division of Health Sciences, Idaho State University, Pocatello, ID, 83209, USA.

ORCID-Profile: Solomon Tadesse

Zitieren

APA

Shrestha, J., Blanchard, J., & Tadesse, S. (2025). Cyclin‐Dependent Kinase 11: Cellular Functions and Potential Therapeutic Applications. ChemMedChem. https://doi.org/10.1002/cmdc.202500305

Vancouver

Shrestha J, Blanchard J, Tadesse S. Cyclin‐Dependent Kinase 11: Cellular Functions and Potential Therapeutic Applications. ChemMedChem. 2025. doi:10.1002/cmdc.202500305

BibTeX
@article{Shrestha2025,
  author = {Shrestha, Janhabee and Blanchard, Jason and Tadesse, Solomon},
  title = {Cyclin‐Dependent Kinase 11: Cellular Functions and Potential Therapeutic Applications},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500305}
}
Kostenlos starten →